Guglielmo Ferrari
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Previous Organizations / Institutes
The organizations / institutes from the scholar's other articles in the past ten years
Research Subjects
Guglielmo Ferrari has a total of 172 co-authors. Here are the top co-authors by number of shared publications:
- Antonio Piralla
Microbiology and Virology Department, Fondazione IRCCS Policlinico San Matteo, 27100 Pavia, Italy
13 shared publications - Fausto Baldanti
Microbiology and Virology Unit, Fondazione IRCCS Policlinico San Matteo, 27100 Pavia, Italy
9 shared publications - Federica Giardina
IQ Health science department, Radboud University Medical Centre, Nijmegen, The Netherlands
7 shared publications - Greta Romano
Microbiology and Virology Department, Fondazione IRCCS Policlinico San Matteo, 27100 Pavia, Italy
6 shared publications - Cristina Galli
Department of Biomedical Sciences for Health, University of Milan, Milan, Italy
4 shared publications - Elena Pariani
Department of Biomedical Sciences for Health, University of Milan, Milan, Italy
4 shared publications
Latest Publications
- Open Access
- 23 June 2026
- Published by MDPI AG in International Journal of Molecular Sciences
- Vol. 27 (13) , 5640
Phylogenetic and Genomic Characterization of Whole Genome Sequences of a Herpes Simplex Virus Type 1 Isolate Identified Genomic Variant Characteristics in a Human Subject with Fulminant Hepatitis
Herpes simplex virus 1 (HSV-1) is a rare cause of acute hepatitis, especially in patients with chronic immunosuppression. We performed whole-genome HSV-1 sequencing with a metagenomics approach on peripheral blood samples from an Italian case of fatal acute liver failure with high circulating HSV-1 (1,129,900,000 copies/mL), followed by phylogenetic analysis. After multiple sequence alignment, a final dataset of 182 whole-genome sequences was selected. The sequenced HSV-1 strain belonged to a phylogenetic clade isolated in Florida in 2002 (OQ724868.1). A characterization of single nucleotide polymorphisms and indels was performed to determine their effects on the viral genome: only one variant, classified as an indel, was detected with a high impact effect (c.905_906insGTTTT) in the UL49A gene, which is known to encode a membrane protein regulating virion morphogenesis, replication and assembly. In addition, this study also detected variants in other genes involved in crucial steps of the HSV-1 life cycle, like alpha-regulation (US7), capsid transport (UL36) and viral polymerase function (UL30). In conclusion, the results of this variant analysis confirmed that in HSV-1 hepatitis, some viral regions may be hotspots for adaptive mutations with a substantial impact on viral replication or immune evasion.
- 23 June 2026
- Published by MDPI AG in International Journal of Molecular Sciences
- Vol. 27 (13) , 5640
Open AccessPhylogenetic and Genomic Characterization of Whole Genome Sequences of a Herpes Simplex Virus Type 1 Isolate Identified Genomic Variant Characteristics in a Human Subject with Fulminant Hepatitis
Herpes simplex virus 1 (HSV-1) is a rare cause of acute hepatitis, especially in patients with chronic immunosuppression. We performed whole-genome HSV-1 sequencing with a metagenomics approach on peripheral blood samples from an Italian case of fatal acute liver failure with high circulating HSV-1 (1,129,900,000 copies/mL), followed by phylogenetic analysis. After multiple sequence alignment, a final dataset of 182 whole-genome sequences was selected. The sequenced HSV-1 strain belonged to a phylogenetic clade isolated in Florida in 2002 (OQ724868.1). A characterization of single nucleotide polymorphisms and indels was performed to determine their effects on the viral genome: only one variant, classified as an indel, was detected with a high impact effect (c.905_906insGTTTT) in the UL49A gene, which is known to encode a membrane protein regulating virion morphogenesis, replication and assembly. In addition, this study also detected variants in other genes involved in crucial steps of the HSV-1 life cycle, like alpha-regulation (US7), capsid transport (UL36) and viral polymerase function (UL30). In conclusion, the results of this variant analysis confirmed that in HSV-1 hepatitis, some viral regions may be hotspots for adaptive mutations with a substantial impact on viral replication or immune evasion.
- Open Access
- 19 January 2026
- Published by Oxford University Press (OUP) in Virus Evolution
- Vol. 12 (1)
Genomic evolution and minority variant dynamics of RSV during the first season of nirsevimab implementation in Italy (2024–5)
Respiratory syncytial virus (RSV) remains a leading cause of hospitalization despite the recent implementation of infant immunoprophylaxis programs. The inter- and intrahost levels of genetic variation across the genome have not been extensively investigated. Hence, the aim of this study was to characterize the whole genome of RSV strains circulating within two Italian areas during the 2024–5 RSV season, corresponding to the first season after implementation of the national nirsevimab prophylaxis program. Whole genome sequencing (WGS) was performed on 88 respiratory samples that tested positive for RSV. Clinical records showed that none of the sequenced patients had received nirsevimab prophylaxis. The WGS strains obtained in the present study were correlated with the RSV strains circulating in Europe using phylogenetic inference. A newly designed bioinformatic pipeline was developed to evaluate the extent of genetic variation within hosts and reveal the distribution of minority mutations among RSV lineages. RSV-A (n = 54) showed significantly higher levels of nucleotide diversity than RSV-B (n = 34). Among the RSV-A strains, lineage A.D.3 was the most prevalent (35/54, 64%), followed by A.D.1 (18/54, 33%). The A.D.5 lineage was identified in only one strain, while all 34 RSV-B strains were found to be lineage B.D.E. Analysis of variants across the major lineages (A.D.1, A.D.3, and B.D.E) revealed heterogeneous mutation patterns. The G, L, and F genes showed the highest variability. Minority viral variants (0.02–0.05 frequency) followed the same gene-specific dynamics as the broader quasispecies population. A > G transitions consistent with ADAR activity were detected in all samples, but their frequency was similar to the other nucleotide substitutions across the genomes. The analysis of minor variants also targeted mutations known to reduce nirsevimab efficacy, and none were detected. Overall, RSV-A showed substantially greater intragenotypic and intrahost diversity than RSV-B. The elevated diversity in RSV-A resulted from a wider distribution of mutations across the viral genome, including both high-frequency substitutions that shaped the consensus sequence and low-frequency variants contributing to the underlying quasispecies complexity. Although no nirsevimab-treated patients were included in this study, the observed intrahost diversity highlights the importance of continued genomic surveillance to detect potential escape variants as prophylactic programs expand.
- 19 January 2026
- Published by Oxford University Press (OUP) in Virus Evolution
- Vol. 12 (1)
Open AccessGenomic evolution and minority variant dynamics of RSV during the first season of nirsevimab implementation in Italy (2024–5)
Respiratory syncytial virus (RSV) remains a leading cause of hospitalization despite the recent implementation of infant immunoprophylaxis programs. The inter- and intrahost levels of genetic variation across the genome have not been extensively investigated. Hence, the aim of this study was to characterize the whole genome of RSV strains circulating within two Italian areas during the 2024–5 RSV season, corresponding to the first season after implementation of the national nirsevimab prophylaxis program. Whole genome sequencing (WGS) was performed on 88 respiratory samples that tested positive for RSV. Clinical records showed that none of the sequenced patients had received nirsevimab prophylaxis. The WGS strains obtained in the present study were correlated with the RSV strains circulating in Europe using phylogenetic inference. A newly designed bioinformatic pipeline was developed to evaluate the extent of genetic variation within hosts and reveal the distribution of minority mutations among RSV lineages. RSV-A (n = 54) showed significantly higher levels of nucleotide diversity than RSV-B (n = 34). Among the RSV-A strains, lineage A.D.3 was the most prevalent (35/54, 64%), followed by A.D.1 (18/54, 33%). The A.D.5 lineage was identified in only one strain, while all 34 RSV-B strains were found to be lineage B.D.E. Analysis of variants across the major lineages (A.D.1, A.D.3, and B.D.E) revealed heterogeneous mutation patterns. The G, L, and F genes showed the highest variability. Minority viral variants (0.02–0.05 frequency) followed the same gene-specific dynamics as the broader quasispecies population. A > G transitions consistent with ADAR activity were detected in all samples, but their frequency was similar to the other nucleotide substitutions across the genomes. The analysis of minor variants also targeted mutations known to reduce nirsevimab efficacy, and none were detected. Overall, RSV-A showed substantially greater intragenotypic and intrahost diversity than RSV-B. The elevated diversity in RSV-A resulted from a wider distribution of mutations across the viral genome, including both high-frequency substitutions that shaped the consensus sequence and low-frequency variants contributing to the underlying quasispecies complexity. Although no nirsevimab-treated patients were included in this study, the observed intrahost diversity highlights the importance of continued genomic surveillance to detect potential escape variants as prophylactic programs expand.
- 24 July 2025
- Published by Oxford University Press (OUP) in Journal of Travel Medicine
- Vol. 32 (6)
Chikungunya cases with vector-adaptive mutations detected in Italy imported from Madagascar
Two imported Chikungunya cases were detected in northern Italy in 2025, linked to the strains circulating in Réunion Island. Genomic analysis revealed mutations enhancing Aedes albopictus transmission. These findings raise concern for local spread and highlight the importance of genomic surveillance, vector control and preparedness against emerging arboviral threats in Europe.
- 24 July 2025
- Published by Oxford University Press (OUP) in Journal of Travel Medicine
- Vol. 32 (6)
Chikungunya cases with vector-adaptive mutations detected in Italy imported from Madagascar
Two imported Chikungunya cases were detected in northern Italy in 2025, linked to the strains circulating in Réunion Island. Genomic analysis revealed mutations enhancing Aedes albopictus transmission. These findings raise concern for local spread and highlight the importance of genomic surveillance, vector control and preparedness against emerging arboviral threats in Europe.
- Open Access
- 15 July 2025
- Published by Oxford University Press (OUP) in The Journal of Infectious Diseases
- Vol. 232 (Supplement) , S109-S120
Multicenter Cross-sectional Study on the Epidemiology of Human Metapneumovirus in Italy, 2022–2024, With a Focus on Adults Over 50 Years of Age
Background: Human metapneumovirus (hMPV) infections have a significant impact on public health. However, the extent of this burden in Italy remains poorly defined due to a lack of comprehensive data. The aim of this cross-sectional multicenter study was to understand the epidemiology of hMPV in Italy, particularly in older adults. Methods: We analyzed laboratory data from molecular respiratory viral diagnostic tests conducted at 17 centers across Italy from September 2022 to August 2024. Respiratory viruses were tested from outpatients for epidemiologic surveillance and from patients presenting to tertiary hospitals for diagnostic purpose. G gene sequencing was performed on a limited number of circulating strains. Results: Data from 96 460 tests yielded an overall hMPV positivity rate of 3.4%; the hMPV positivity rate was 2.6% in adults aged 50 years and older, a third of whom were aged >80 years. In north-west Italy, hMPV was detected more frequently in outpatients than in hospitalized patients. The temporal distribution of cases showed seasonal peaks in February 2023 and April 2024, which exhibited some geographic variation but overlapped in the general population and in the elderly. Phylogenetic analysis suggested an even distribution of hMPV-A and -B, with a predominance of clades A2c with a 111-nucleotide duplication and B2b, and the possible extinction of previously circulating clades A2c with a 180-nucleotide duplication and B2a. Conclusions: hMPV was shown to be a relevant respiratory pathogen in older adults, who could be more likely to have severe outcomes. These findings may inform hMPV surveillance and the development of prevention strategies.
- 15 July 2025
- Published by Oxford University Press (OUP) in The Journal of Infectious Diseases
- Vol. 232 (Supplement) , S109-S120
Open AccessMulticenter Cross-sectional Study on the Epidemiology of Human Metapneumovirus in Italy, 2022–2024, With a Focus on Adults Over 50 Years of Age
Background: Human metapneumovirus (hMPV) infections have a significant impact on public health. However, the extent of this burden in Italy remains poorly defined due to a lack of comprehensive data. The aim of this cross-sectional multicenter study was to understand the epidemiology of hMPV in Italy, particularly in older adults. Methods: We analyzed laboratory data from molecular respiratory viral diagnostic tests conducted at 17 centers across Italy from September 2022 to August 2024. Respiratory viruses were tested from outpatients for epidemiologic surveillance and from patients presenting to tertiary hospitals for diagnostic purpose. G gene sequencing was performed on a limited number of circulating strains. Results: Data from 96 460 tests yielded an overall hMPV positivity rate of 3.4%; the hMPV positivity rate was 2.6% in adults aged 50 years and older, a third of whom were aged >80 years. In north-west Italy, hMPV was detected more frequently in outpatients than in hospitalized patients. The temporal distribution of cases showed seasonal peaks in February 2023 and April 2024, which exhibited some geographic variation but overlapped in the general population and in the elderly. Phylogenetic analysis suggested an even distribution of hMPV-A and -B, with a predominance of clades A2c with a 111-nucleotide duplication and B2b, and the possible extinction of previously circulating clades A2c with a 180-nucleotide duplication and B2a. Conclusions: hMPV was shown to be a relevant respiratory pathogen in older adults, who could be more likely to have severe outcomes. These findings may inform hMPV surveillance and the development of prevention strategies.
- Open Access
- 24 February 2025
- Published by Elsevier in IJID Regions
- Vol. 15, 100609
Genomic surveillance and evolutionary dynamics of respiratory syncytial virus circulating in Tunisia post–COVID-19 pandemic lockdown restrictions
- 24 February 2025
- Published by Elsevier in IJID Regions
- Vol. 15, 100609
Open AccessGenomic surveillance and evolutionary dynamics of respiratory syncytial virus circulating in Tunisia post–COVID-19 pandemic lockdown restrictions
- Open Access
Unexpected Pediatric Cluster of Enterovirus C105, Verona, Italy
In an epidemiologic investigation of Enterovirus (EV) infections in a Verona hospital, September 2022–September 2024, we detected EV-C105 in six pediatric patients with upper respiratory symptoms between March and May 2023. The primary objective was to describe the local incidence of EV cases. The secondary objective was to perform Sanger’s genomic characterization and the whole-genome sequencing (WGS) of EV-C105. The proportion of positive EV results was calculated based on routine molecular method testing. An available cohort of 114 underwent Sanger sequencing, and the six EV-C105 were characterized with WGS. Overall, 96% EV results were from the upper respiratory tract. The total proportion of positives in children was 83%. Out of the typed 114, 90% were Rhinoviruses and 9%, EVs. Notably, six pediatric cases were EV-C105, placing together in a unique cluster with 99% of nucleotides belonging to the European lineage with the highest Average Nucleotide Identity, including EV-C104, EV-C109, and EV-C118. Our data describes the first cluster indicating that EV-C105 incidence may be higher than previously estimated. However, a limitation for affirming this hypothesis is the lack of a more in-depth epidemiological investigation on a larger case series with the possibility of including data from coordinated laboratories.
Open AccessUnexpected Pediatric Cluster of Enterovirus C105, Verona, Italy
In an epidemiologic investigation of Enterovirus (EV) infections in a Verona hospital, September 2022–September 2024, we detected EV-C105 in six pediatric patients with upper respiratory symptoms between March and May 2023. The primary objective was to describe the local incidence of EV cases. The secondary objective was to perform Sanger’s genomic characterization and the whole-genome sequencing (WGS) of EV-C105. The proportion of positive EV results was calculated based on routine molecular method testing. An available cohort of 114 underwent Sanger sequencing, and the six EV-C105 were characterized with WGS. Overall, 96% EV results were from the upper respiratory tract. The total proportion of positives in children was 83%. Out of the typed 114, 90% were Rhinoviruses and 9%, EVs. Notably, six pediatric cases were EV-C105, placing together in a unique cluster with 99% of nucleotides belonging to the European lineage with the highest Average Nucleotide Identity, including EV-C104, EV-C109, and EV-C118. Our data describes the first cluster indicating that EV-C105 incidence may be higher than previously estimated. However, a limitation for affirming this hypothesis is the lack of a more in-depth epidemiological investigation on a larger case series with the possibility of including data from coordinated laboratories.
- Open Access
Tracing the Origin, Spread, and Molecular Evolution of Dengue Type 1 Cases That Occurred in Northern Italy in 2023
The dengue virus (DENV) is a mosquito-borne flavivirus endemic to many tropical and subtropical regions. Over the past few decades, the global incidence of dengue has risen dramatically, with the virus now present in over 100 countries, putting nearly half of the world’s population at risk. This increase is attributed to several factors, including urbanization, climate change, and global travel, which facilitate the spread of both the virus and its mosquito vectors. While dengue is primarily associated with tropical regions, outbreaks in temperate areas are becoming increasingly common due to the spread of Aedes albopictus, a competent vector for DENV that can adapt to cooler climates. This study investigates the molecular dynamics and geographic evolution of DENV type 1 (DENV-1) strains isolated from 13 patients during an autochthonous outbreak in Lombardy, Northern Italy, between August and September 2023. Additionally, Aedes albopictus mosquitoes were collected from a neighboring area to assess their potential role in the outbreak. A metagenomic approach was used to recover DENV-1 consensus sequences from clinical samples. Genotype classification and phylogenetic analyses were performed using Bayesian methods and a comprehensive dataset of DENV-1 sequences from other countries. The Italian autochthonous strains clustered with South American strains collected between 2020 and 2023, specifically those belonging to genotype V, subtype D. Bayesian analysis estimated a mean evolutionary substitution rate of 8.234 × 10−4 substitutions per site per year (95% HPD interval: 7.1448 × 10−4–9.3343 × 10−4), with the time to the most recent common ancestor (tMRCA) dating back to 1972 (95% HPD interval: 1968–1976). These findings suggest the likely introduction of the virus into the region from endemic areas in South America, followed by local transmission. This study offers valuable insights into the dynamics of the DENV-1 outbreak in Lombardy, underscoring the importance of genomic surveillance in monitoring viral spread and evolution. The findings emphasize the critical need for enhanced molecular and entomological surveillance to detect and respond to emerging autochthonous DENV cases in temperate regions where competent vectors, such as Aedes albopictus, are present. Public health strategies should prioritize integrated vector management, real-time genomic monitoring, and awareness campaigns to mitigate the risk of future outbreaks. These measures are essential to address the growing threat posed by the geographic expansion of the dengue virus.
Open AccessTracing the Origin, Spread, and Molecular Evolution of Dengue Type 1 Cases That Occurred in Northern Italy in 2023
The dengue virus (DENV) is a mosquito-borne flavivirus endemic to many tropical and subtropical regions. Over the past few decades, the global incidence of dengue has risen dramatically, with the virus now present in over 100 countries, putting nearly half of the world’s population at risk. This increase is attributed to several factors, including urbanization, climate change, and global travel, which facilitate the spread of both the virus and its mosquito vectors. While dengue is primarily associated with tropical regions, outbreaks in temperate areas are becoming increasingly common due to the spread of Aedes albopictus, a competent vector for DENV that can adapt to cooler climates. This study investigates the molecular dynamics and geographic evolution of DENV type 1 (DENV-1) strains isolated from 13 patients during an autochthonous outbreak in Lombardy, Northern Italy, between August and September 2023. Additionally, Aedes albopictus mosquitoes were collected from a neighboring area to assess their potential role in the outbreak. A metagenomic approach was used to recover DENV-1 consensus sequences from clinical samples. Genotype classification and phylogenetic analyses were performed using Bayesian methods and a comprehensive dataset of DENV-1 sequences from other countries. The Italian autochthonous strains clustered with South American strains collected between 2020 and 2023, specifically those belonging to genotype V, subtype D. Bayesian analysis estimated a mean evolutionary substitution rate of 8.234 × 10−4 substitutions per site per year (95% HPD interval: 7.1448 × 10−4–9.3343 × 10−4), with the time to the most recent common ancestor (tMRCA) dating back to 1972 (95% HPD interval: 1968–1976). These findings suggest the likely introduction of the virus into the region from endemic areas in South America, followed by local transmission. This study offers valuable insights into the dynamics of the DENV-1 outbreak in Lombardy, underscoring the importance of genomic surveillance in monitoring viral spread and evolution. The findings emphasize the critical need for enhanced molecular and entomological surveillance to detect and respond to emerging autochthonous DENV cases in temperate regions where competent vectors, such as Aedes albopictus, are present. Public health strategies should prioritize integrated vector management, real-time genomic monitoring, and awareness campaigns to mitigate the risk of future outbreaks. These measures are essential to address the growing threat posed by the geographic expansion of the dengue virus.
- Open Access
A newly developed whole genome sequencing protocol enables early tracking of Enterovirus D68 molecular evolution
Background Human enterovirus D68 (EV-D68) has been associated with an increase in mild-to-severe pediatric respiratory diseases worldwide. The rate of circulation of this virus is largely underestimated in the population and genetic evolutionary data are usually available only for partial sequences (e.g VP1 region). To achieve a timely genomic surveillance, a reliable, high-throughput EV-68 sequencing assay is required. Here we report an improved high-throughput EV-D68 whole-genome sequencing (WGS) assay performed directly on clinical samples that is suitable for short-read sequencing platforms. Between June and December 2022, a total 37 (1.9%) respiratory samples were EV-D68 positive and together with 52 additional samples with a median cycle threshold of 28.3, ranging from 18 to 36.8 were included in the validation analyses. Overall, all the primers had good performance and no mismatches were detected in more than 85% of sequences (932 WGS dataset). Using a cut-off of Cq <32 in at least 85.5% of samples a WG or PG was obtained, confirming an acceptable positive sequencing rate for the designed method. A total of 65 WGS were obtained and have a mean coverage of 98.4% across the genome, with a median depth of 6158x (range 2815x-7560x). Based on the obtained data, this method is cost effective resulting in an easy-to-perform protocol helpful for tracing the evolution of EV-D68 in protein different from VP1. EV-D68 could become a significant pathogen for public health in the next future, and thus this protocol for whole genome sequencing could help clinical and molecular virologists to be ready for molecular epidemiology surveillance.
Open AccessA newly developed whole genome sequencing protocol enables early tracking of Enterovirus D68 molecular evolution
Background Human enterovirus D68 (EV-D68) has been associated with an increase in mild-to-severe pediatric respiratory diseases worldwide. The rate of circulation of this virus is largely underestimated in the population and genetic evolutionary data are usually available only for partial sequences (e.g VP1 region). To achieve a timely genomic surveillance, a reliable, high-throughput EV-68 sequencing assay is required. Here we report an improved high-throughput EV-D68 whole-genome sequencing (WGS) assay performed directly on clinical samples that is suitable for short-read sequencing platforms. Between June and December 2022, a total 37 (1.9%) respiratory samples were EV-D68 positive and together with 52 additional samples with a median cycle threshold of 28.3, ranging from 18 to 36.8 were included in the validation analyses. Overall, all the primers had good performance and no mismatches were detected in more than 85% of sequences (932 WGS dataset). Using a cut-off of Cq <32 in at least 85.5% of samples a WG or PG was obtained, confirming an acceptable positive sequencing rate for the designed method. A total of 65 WGS were obtained and have a mean coverage of 98.4% across the genome, with a median depth of 6158x (range 2815x-7560x). Based on the obtained data, this method is cost effective resulting in an easy-to-perform protocol helpful for tracing the evolution of EV-D68 in protein different from VP1. EV-D68 could become a significant pathogen for public health in the next future, and thus this protocol for whole genome sequencing could help clinical and molecular virologists to be ready for molecular epidemiology surveillance.
- Open Access
- 26 July 2024
- Published by Elsevier in IJID Regions
- Vol. 12, 100411
A new case of Echovirus 11 neonatal fulminant hepatitis involving male twins in a Northern Italy Tertiary University Hospital: Insight on a possible immunological clue
- 26 July 2024
- Published by Elsevier in IJID Regions
- Vol. 12, 100411
Open AccessA new case of Echovirus 11 neonatal fulminant hepatitis involving male twins in a Northern Italy Tertiary University Hospital: Insight on a possible immunological clue
- Open Access
- 7 March 2024
- Published by Elsevier in International Journal of Infectious Diseases
- Vol. 142, 106998
Increased circulation of echovirus 11 in the general population and hospital patients as elicited by the non-polio enterovirus laboratory-based sentinel surveillance in northern Italy, 2023
- 7 March 2024
- Published by Elsevier in International Journal of Infectious Diseases
- Vol. 142, 106998
Open AccessIncreased circulation of echovirus 11 in the general population and hospital patients as elicited by the non-polio enterovirus laboratory-based sentinel surveillance in northern Italy, 2023